Oncocyte is now iMDx! Click here to learn more.

Transforming Diagnostics. Empowering Care.

Precision diagnostics in oncology and transplantation—delivered with purpose, powered by science.

ABOUT iMDx

Science with Purpose

At iMDx, we advance precision medicine through innovative diagnostics that serve the needs of researchers, clinicians, and healthcare systems. Whether enabling early detection, guiding treatment, or accelerating discovery, our solutions are designed to deliver clear, actionable insights that drive better decisions across the continuum of care.

CLINICAL & RESEARCH PRODUCTS

Actionable Insights at Every Step

Our molecular diagnostic solutions are built to support decision-making across clinical practice, translational research, and laboratory operations. From transplant monitoring to cancer immunotherapy guidance, we provide accurate, scalable tools that drive discovery, streamline workflows, and enable more informed decisions in both clinical and research settings.

Blood-based transplant monitoring test that quantifies the concentration of donor-derived cell-free DNA (dd-cfDNA) following transplantation

(in development) A clinical assay intended to quantify relative (%) and absolute (cp/mL) levels of donor-derived cell-free DNA (dd-cfDNA) in plasma following kidney transplantation

Research use only blood-based dd-cfDNA test kit that quantifies the concentration of donor-derived cell-free DNA (dd-cfDNA) following transplantation

In-development test that measures genomic copy number instability in circulating tumor DNA to monitor therapeutic efficacy in cancer patients

27-gene expression laboratory developed test that assesses the tumor microenvironment to predict likelihood of response to immunotherapies

Research use only 27- gene expression assay test kit that assesses the tumor microenvironment

OUR VALUES

Guided by Purpose, Grounded in Values

Everything we do is shaped by a shared commitment to patients, science, and each other.

PILLARS

Patient First
Integrity
Innovation
One Team
Courageous

FOR INVESTORS

Investing in the future of precision medicine

At Insight Molecular Diagnostics Inc., (iMDx), we’re investing in a mission to democratize access to molecular diagnostic testing, and helping the healthcare industry deliver upon the promises of precision medicine. Our focus is on transplant and oncology, two of the fastest-growing areas in diagnostics, where better tools can create sustainable long-term value for researchers, clinicians, hospitals, and patients.

We’re innovating beyond designing laboratory tests — we’re building a platform for global accessibility to transformative care.

LATEST NEWS

Insights & Innovations